Looking for volunteers
Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques
NCT06687408 · Second Affiliated Hospital, Zhejiang University, School of Medicine · Updated 24 April 2026
- What is being tested
- RATS Group; VATS group
- For
- Lung Cancer, Non-Small Cell
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 450 people. The full rules are on the registry page.
- Where
- China (3 sites)
- When
- Starts or started 1 March 2025, ends 31 Dec 2027. Registered 13 Nov 2024.
- Results
- None posted yet.
In the researchers' words
The goal of this multicenter observational study is to evaluate the long-term survival and perioperative outcomes of sleeve lobectomy in robotic-assisted thoracic surgery (RATS) for patients with central lung cancer when compared with video-assisted thoracic surgery (VATS) approach, both of which have been already applied to these patients in minimally invasive surgical techniques as part of their regular medical care recently. The main question it aims to answer is: Are RATS sleeve lobectomy associated with similar or even better long-term survival and perioperative outcomes for patients with central lung cancer when compared with the VATS approach?
Sites
- The Second Affiliated Hospital Zhejiang University School of MedicineHangzhou, China
- Sir Run Run Shaw Hospital, Medical College, Zhejiang UniversityHangzhou, China
- Shanghai Chest Hospital, Shanghai Jiao Tong UniversityShanghai, China